Monte Rosa Therapeutics Inc (GLUE) — Capital Reinvestment Ratio
Monte Rosa Therapeutics Inc (GLUE) has a Capital Reinvestment Ratio of 0.01x as of September 2025, meaning it reinvests 0% of its operating cash flow ($100.43 Million) in capital expenditures ($651.00K). Check GLUE goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Monte Rosa Therapeutics Inc Capital Reinvestment Ratio (2024–2024)
This chart tracks Monte Rosa Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see how efficiently does Monte Rosa Therapeutics Inc generate cash.
Annual Capital Reinvestment Ratio for Monte Rosa Therapeutics Inc (2024–2024)
Year-by-year Capital Reinvestment Ratio for Monte Rosa Therapeutics Inc from 2024 to 2024. See Monte Rosa Therapeutics Inc (GLUE) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.09x | $42.00 Million | $3.99 Million | — |